CDC reports cases of multisystem inflammatory syndrome in adults

CDC reports cases of multisystem inflammatory syndrome in adults

(HealthDay)—Adult patients with current or previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can develop a hyperinflammatory syndrome, which resembles multisystem inflammatory syndrome in children (MIS-C), according to a case series published in the Oct. 2 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Sapna Bamrah Morris, M.D., from the CDC COVID-19 Response Team, and colleagues present reports of 27 patients with cardiovascular, gastrointestinal, dermatologic, and neurologic symptoms without severe respiratory illness who concurrently received positive test results for SARS-CoV-2.

The researchers highlight recognition of multisystem inflammatory syndrome in adults (MIS-A), which resembles MIS-C. The patients described had minimal respiratory symptoms, hypoxemia, or radiographic abnormalities. In case reports describing MIS-A, only eight of 16 patients had any documented respiratory symptoms before onset of MIS-A. All 16 patients had evidence of cardiac effects, 13 had on admission, and five had dermatologic manifestations. Ten of the patients had pulmonary ground-glass opacities, and six had pleural effusions on chest imaging, despite minimal respiratory symptoms. Ten of the patients had positive SARS-CoV-2 polymerase chain reaction (PCR) test results at the time of initial assessment. Six had negative SARS-CoV-2 PCR results, but four had positive anti-SARS-CoV-2 antibody results and two had positive SARS-CoV-2 PCR test results between 14 and 37 days before admission.

"Clinical suspicion and indicated SARS-CoV-2 testing, including antibody testing, might be needed to recognize and treat adults with MIS-A. Further research is needed to understand the pathogenesis and long-term effects of this condition," the authors write. "Ultimately, the recognition of MIS-A reinforces the need for prevention efforts to limit spread of SARS-CoV-2."

Several authors disclosed financial ties to the pharmaceutical industry.

More information: Abstract/Full Text

Copyright © 2020 HealthDay. All rights reserved.

Citation: CDC reports cases of multisystem inflammatory syndrome in adults (2020, October 6) retrieved 31 January 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak


Feedback to editors